Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Chemical Immunology
|
December 23, 1999
Structure/function relationships of CD14
F Stelter
Biomedica Biochimica Acta
|
January 1, 1990
Complement component 3 (C3) genetics and diabetes mellitus
S Krantz, F Stelter, M Lober, et al.
Journal of Immunological Methods
|
May 12, 1997
CHO transfectants produce large amounts of recombinant protein in suspension culture
C Schütt, B Fürll, F Stelter, et al.
European Journal of Immunology
|
May 1, 1995
Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria
R S Jack, U Grunwald, F Stelter, et al.
Experimental and Clinical Endocrinology
|
March 1, 1988
Complement component 3 (C 3) and diabetes mellitus
S Krantz, F Stelter, M Lober, et al.
European Journal of Clinical Investigation
|
May 6, 1998
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models
F Stelter, S Witt, B Fürll, et al.
Infection and Immunity
|
May 25, 1999
Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction
X Fan, F Stelter, R Menzel, et al.
Archives of Virology
|
October 14, 2004
A temperature-dependent inhibitory activity of serum on the capacity of Saccharomyces cerevisiae-derived hepatitis B surface antigen to bind to monocytes
P Vanlandschoot, F Van Houtte, A Roobrouck, et al.
Infection and Immunity
|
March 1, 1995
Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14
H Loppnow, F Stelter, U Schönbeck, et al.
European Journal of Biochemistry
|
March 1, 1996
The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms
F Stelter, M Pfister, M Bernheiden, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Chemical Immunology
|
December 23, 1999
Structure/function relationships of CD14
F Stelter
Biomedica Biochimica Acta
|
January 1, 1990
Complement component 3 (C3) genetics and diabetes mellitus
S Krantz, F Stelter, M Lober, et al.
Journal of Immunological Methods
|
May 12, 1997
CHO transfectants produce large amounts of recombinant protein in suspension culture
C Schütt, B Fürll, F Stelter, et al.
European Journal of Immunology
|
May 1, 1995
Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria
R S Jack, U Grunwald, F Stelter, et al.
Experimental and Clinical Endocrinology
|
March 1, 1988
Complement component 3 (C 3) and diabetes mellitus
S Krantz, F Stelter, M Lober, et al.
European Journal of Clinical Investigation
|
May 6, 1998
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models
F Stelter, S Witt, B Fürll, et al.
Infection and Immunity
|
May 25, 1999
Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction
X Fan, F Stelter, R Menzel, et al.
Archives of Virology
|
October 14, 2004
A temperature-dependent inhibitory activity of serum on the capacity of Saccharomyces cerevisiae-derived hepatitis B surface antigen to bind to monocytes
P Vanlandschoot, F Van Houtte, A Roobrouck, et al.
Infection and Immunity
|
March 1, 1995
Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14
H Loppnow, F Stelter, U Schönbeck, et al.
European Journal of Biochemistry
|
March 1, 1996
The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms
F Stelter, M Pfister, M Bernheiden, et al.
Page
of 3